Most ultra-expensive drugs in USA provide low added benefit

    This is a preview of subscription content, access via your institution.

    Notes

    1. 1.

      2018 US dollars

    Reference

    1. DiStefano MJ, et al. Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs. Value in Health : 6 Jan 2021. Available from: URL: https://doi.org/10.1016/j.jval.2020.10.021

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Most ultra-expensive drugs in USA provide low added benefit. PharmacoEcon Outcomes News 870, 15 (2021). https://doi.org/10.1007/s40274-021-7418-4

    Download citation